ReviewInternational journal of molecular sciences2022

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials.

Marco de Scordilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.